Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FVIII-PEGLip in Severe Haemophilia A
NCT04592692Phase 2Unknown
- Sponsor
- Ascension
- Start
- Dec 2019
- Primary completion
- Feb 2022
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposome simoctocog alfa in hemophilia A, sponsored by Ascension. Status: unknown.
02
Drugs
pegylated liposome simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04592692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592692.